Literature DB >> 23546748

Generation of human-induced pluripotent stem cells (hiPSCs) using episomal vectors on defined Essential 8™ Medium conditions.

Andrew Fontes1, Chad C Macarthur, Pauline T Lieu, Mohan C Vemuri.   

Abstract

Human-induced pluripotent stem cells (iPSCs) are an important potential source of cells for regenerative medicine due to their inherent ability to differentiate into all cell types of the three germ layers. Generation of iPSCs with a non-integrating reprogramming method and in culture conditions that are completely absent of animal proteins will be ideal for such regenerative and cell therapy applications. Here we describe a method to generate non-integrating iPSCs using the Episomal iPSC Reprogramming Vectors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23546748     DOI: 10.1007/978-1-62703-348-0_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Induced pluripotent stem cells for regenerative medicine.

Authors:  Karen K Hirschi; Song Li; Krishnendu Roy
Journal:  Annu Rev Biomed Eng       Date:  2014-05-29       Impact factor: 9.590

2.  Chronic VEGFR-3 signaling preserves dendritic arborization and sensitization under stress.

Authors:  Adri Chakraborty; Raghavendra Upadhya; Timaj A Usman; Ashok K Shetty; Joseph M Rutkowski
Journal:  Brain Behav Immun       Date:  2021-08-11       Impact factor: 7.217

3.  Non-viral generation of marmoset monkey iPS cells by a six-factor-in-one-vector approach.

Authors:  Katharina Debowski; Rita Warthemann; Jana Lentes; Gabriela Salinas-Riester; Ralf Dressel; Daniel Langenstroth; Jörg Gromoll; Erika Sasaki; Rüdiger Behr
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

4.  Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction.

Authors:  Ling Zhou; Peng Li; Na Chen; Li-Fang Dai; Kai Gao; Yi-Nan Liu; Li Shen; Jing-Min Wang; Yu-Wu Jiang; Ye Wu
Journal:  CNS Neurosci Ther       Date:  2019-02-05       Impact factor: 5.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.